Congress may soon clear federal restrictions to processing marijuana transactions, while the FDA asks for feedback on handling marijuana products.
Congress may soon clear federal restrictions to processing marijuana transactions, while the FDA asks for feedback on handling marijuana products.
With an enormous range of initiatives to prevent and treat opioid use disorder, the bill has officially been signed by the President.
